The Missouri Senate has passed legislation that could lower the cost of receiving oral chemotherapy treatments.
Senators voted 33-0 on Thursday to send the measure to the House. It would let insurance companies charge patients only $75 more per month for chemotherapy pills than traditional intravenous chemotherapy treatments.
Patients are often charged much more for oral chemotherapy because it is handled as a pharmacy benefit. Traditional intravenous treatments often only cost the standard co-payment for an office visit.
The legislation is sponsored by Republican Sen. Ryan Silvey, of Kansas City.
27 states and the District of Columbia already have laws requiring equal coverage for oral and intravenous chemotherapy treatments.